Dysphagia Management Market

Global Market Study on Dysphagia Management: Targeting the Geriatric and Paediatric Patient Pool

Dysphagia Management Market is segmented by Drugs (Proton Pump Inhibitors), Feeding Tubes, Nutritional Solutions, Oropharangeal Dysphagia, Esophageal Dysphagia

  • September-2019
  • PMRREP12988
  • 152 Pages
  • Healthcare


Oropharyngeal dysphagia (OD) has been the highly prevalent form of dysphagia, according to indications of research studies and surveys. However, greater prominence of OD has been observed among the elderly patient population.

While OD remains among the most predominant precursors to the growth of dysphagia management market, a new Persistence Market Research (PMR) study expects an overall healthy growth outlook for the global dysphagia management market.

Towards the end of the next decade, the demand for dysphagia management solutions is likely to account for the revenues of more than US$ 6 Bn, and the prevalence rate of OD is anticipated to be rising by 30-40%, in independently living elderly people.

dysphagia management market

Increasing prevalence of various cancers, especially oral cancer, increases the problem of dysphagia in many people. Moreover, some cancer treatments may also cause swallowing difficulties, as a side effect, leading to an increased need of proper dysphagia supplement to avoid further resulting complications.

Find Out More about the Report Coverage


  • Eisai Co. Ltd.
  • Becton, Dickinson and Company (BD)
  • AstraZeneca Plc.
  • Cipla Limited
  • Nestlé (Nestlé Health Science)
  • Kent Corporation (Kent Precision Foods Group, Inc.)
  • Danone (Nutricia Advanced Medical Nutrition)
  • Cook Group (Cook Medical Inc.)

Neurological Causes of Dysphagia Such as Parkinson’s and Stroke to Fuel the Dysphagia Management Market Growth

The onset of Parkinson’s disease and stroke also increases the rate of dysphagia affected patients. Studies suggest that ~50% of Parkinson’s patients show symptoms consistent with oropharyngeal dysphagia. This, in turn, is propelling the demand for dysphagia management products.

Dysphagia management has become imperative in geriatric as well as pediatric population, in the backdrop of serious consequences of choking. Several options available for dysphagia management involve the usage of proton pump inhibitors, feeding tubes, and nutritional solutions such as thickeners and beverages. Suitable dysphagia management option is chosen on the basis of the severity of the condition.

Dysphagia is one of the major side effects of smoking cigarette for a prolonged duration. While smoking tobacco tends to kill around 6 million people per year, this fuels the growth of the dysphagia management market gradually due to rising incidence of oropharyngeal cancers. In developed nations, lack of availability of work and excess free time instigates smoking in contrast to developing nations.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Increasing Cases of Stroke to Heighten the Demand for Dysphagia Management

Insufficient blood supply (oxygen and nutrients) to the brain leads to cerebrovascular accident causing strokes. According to a recent study carried out in the U.K. by stroke association, 40% of the stroke survivors suffer from dysphagia. This provide momentum to the dysphagia management market.

According to World Heart Association, the incidence rate of stroke at the global front is ~ 15 Mn, out of which ~ 6 Mn people die and 6 Mn are left disabled, leading to loss of vision and speech disability. Thus, the increasing prevalence of stroke leading to dysphagia and other complications related to pharynx and larynx are boosting the growth of the dysphagia management market.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Dysphagia Management Penetrating Rapidly in Asia Pacific

In terms of value, Asia Pacific is estimated to be the prominent market for dysphagia management, in 2019, and is expected to expand at a steady CAGR over the forecast period.

While this can be attributed to a high number of pediatric population within the developing countries within the region, so, increasing number hospital and retail pharmacies also contribute to the availability of dysphagia management avenues in these regions. North America is expected to closely follow the Asia pacific region and is anticipated to grow at a CAGR of ~ 5% in the dysphagia management market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Business Expansion Remains the Focal Point in Dysphagia Management Market

Some of the key players operating in the dysphagia management market are -

  • Eisai Co. Ltd.
  • Becton
  • Dickinson and Company (BD)
  • AstraZeneca Plc.
  • Cipla Limited
  • Nestlé (Nestlé Health Science)
  • Kent Corporation
  • Danone
  • Cook Group (Cook Medical Inc.)

One of the key strategies adopted by prominent market participants in the dysphagia management landscape includes channelization of their focus on acquiring smaller players in the dysphagia market. Additionally, they are expected to maintain the focus on business expansion in the dysphagia management space, across the nations other than their primary regional markets.

For instance, in December, 2017, Becton, Dickinson and Company (BD) acquired Bard, with an objective to achieve manifold expansion of the dysphagia management business. More recently in April, 2018, Nestle announced heavy investments as worth as ~ US$ 150 Mn in its two manufacturing units based in China, to expand in the nutritional products space, thereby pushing the growth of their dysphagia management business.

Analyst’s Viewpoint

A comprehensive perspective of the dysphagia management market has led our research analysts to infer that the market is growing at a remarkable rate, with Asia Pacific and North America leading the global market and its product offerings.

The rising number of neurological diseases and disorders are anticipated to provide huge growth opportunities for the key players in the dysphagia management market. Also, the problem of dysphagia linked to post-cancer treatment remains as contributing factor in the growth of the global dysphagia management market.

Key Segments of the Dysphagia Management Market

PMR’s research on the dysphagia management market provides information organized into four critical segments - product type, indication, distribution channel, and region. This report compiles extensive market research information and data on the important business dynamics and development parameters linked with these classifications.

Product Type
  • Drugs (Proton Pump Inhibitors)
  • Feeding Tubes

    • Naso-Gastric Tubes
    • PEG Tubes
  • Nutritional Solutions
    • Thickeners
    • Beverages
    • Puree
  • Oropharangeal Dysphagia
  • Esophageal Dysphagia
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Specialty Clinics
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Questions Answered in PMR’s Dysphagia Management Market Report

  • Which variables could alter the demand for dysphagia management during the evaluated and forecast period?
  • What are the restraints that investors need to be aware of and might tackle while investing in the dysphagia management market?
  • What are the trends in dysphagia management sector that will impact the market?
  • Which business approaches are the key companies taking to prosper in the dysphagia management market?
  • Which regions will stay the most lucrative markets for market participants in dysphagia management?
  • How businesses in the dysphagia management market can avail the growth opportunities in developed and emerging sectors?


Intravitreal (IVT) Injectable Market

Patients having chronic retinal diseases often require repeated dosages of intravitreal (IVT) injectables and thus, the intravitreal (IVT) injectables market is likely to grow at a significant pace during the forecast period. .

Human Insulin Market

The global human insulin market is slated to reach US$ 44 Bn in the year 2022 and reach US$ 70.68 Bn at a CAGR of 8% between 2022 and 2028..

Effervescent Products Market

The Global Effervescent Products market is expected to have a CAGR of 6.50% from USD 41,217.9 Million in 2022 to USD 64,088.9 Million in 2029..

Osteoporosis Drugs Market

Osteoporosis Drugs Market is expected to progress at a modest CAGR of 3.8% from 2021 to 2031, to account for US$ 18 Bn by 2031.

Our Clients

Our Clients